Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapy symbols : Siox save search
Sio Gene Therapies Announces Fiscal Year 2021 Year-End Financial Results
Published: 2022-06-14 (Crawled : 12:00) - biospace.com/
ROIV | $10.795 -0.42% 1.3M
|
Manufacturing
|
| O: 1.42%
H: 8.68%
C: 4.62%
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: 1.35%
H: 2.78%
C: -1.39%
year results therapy
Sio Gene Therapies Announces Prioritization of Lead Gene Therapy Programs in GM1 and GM2 Gangliosidosis, Extension of Cash Runway, and CEO Transition
Published: 2022-01-31 (Crawled : 23:00) - biospace.com/
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: -1.87%
H: 14.29%
C: 11.43%
gene therapy program ceo gene therapies therapy
Sio Gene Therapies Announces Corporate Updates and Fiscal Second Quarter 2021 Financial Results
Published: 2021-11-12 (Crawled : 23:00) - biospace.com/
ROIV | $10.795 -0.42% 1.3M
|
Manufacturing
|
| O: -0.38%
H: 9.11%
C: 7.83%
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: -4.48%
H: 4.17%
C: 3.65%
financial results gene therapies results therapy gene therapy
Sio Gene Therapies Announces Successful Manufacture of Three GMP Batches of AXO-Lenti-PD Gene Therapy for Parkinson’s Disease
Published: 2021-11-11 (Crawled : 14:00) - biospace.com/
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: 2.07%
H: 2.54%
C: 2.03%
disease gene therapies gene therapy therapy parkinson
Sio Gene Therapies Announces Granting of FDA Fast Track Designation for Investigational AXO-AAV-GM2 Gene Therapy in Patients with GM2 Gangliosidosis
Published: 2021-11-01 (Crawled : 19:00) - biospace.com/
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: 0.0%
H: 6.28%
C: 6.28%
fda fda fast track gene therapies fast track gene therapy therapy fast track designation designation
Sio Gene Therapies Announces Reorganization of R&D Group
Published: 2021-10-21 (Crawled : 22:00) - globenewswire.com
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: -3.39%
H: 3.95%
C: -11.4%
gene therapies therapy gene therapy
Sio Gene Therapies Announces Granting of FDA Fast Track Designation for Investigational AXO-AAV-GM1 (AAV9-GLB1) Gene Therapy in Patients with GM1 Gangliosidosis
Published: 2021-10-21 (Crawled : 17:00) - biospace.com/
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: 9.3%
H: 12.98%
C: 0.43%
fda fda fast track gene therapies fast track gene therapy therapy aav9 fast track designation designation
Sio Gene Therapies Announces Positive Interim Safety and Biomarker Data from Ongoing Phase 1/2 Clinical Study of AXO-AAV-GM1 Gene Therapy in GM1 Gangliosidosis
Published: 2021-10-21 (Crawled : 11:00) - biospace.com/
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: 9.3%
H: 12.98%
C: 0.43%
ongoing gene therapies phase 1 gene therapy positive therapy biomarkers
UPDATE: Sio Gene Therapies to Present New Data at the European Society of Gene and Cell Therapy Virtual Congress 2021
Published: 2021-10-04 (Crawled : 13:15) - globenewswire.com
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: 5.58%
H: 6.02%
C: 0.88%
europe gene therapies therapy gene therapy
Sio Gene Therapies to Present New Data at the European Society of Gene and Cell Therapy Virtual Congress 2021
Published: 2021-10-04 (Crawled : 12:00) - globenewswire.com
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: 5.58%
H: 6.02%
C: 0.88%
europe gene therapies therapy gene therapy
Sio Gene Therapies to Participate in Upcoming Conferences
Published: 2021-09-23 (Crawled : 12:00) - globenewswire.com
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: 0.0%
H: 3.02%
C: 2.59%
gene therapies conference therapy gene therapy
Sio Gene Therapies Announces Dosing of First GM1 Gangliosidosis Early Infantile (Type I) Patient in Ongoing Phase 1/2 Study of AXO-AAV-GM1 Gene Therapy
Published: 2021-09-09 (Crawled : 19:00) - biospace.com/
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: 0.0%
H: 9.13%
C: 6.25%
ongoing gene therapies phase 1 gene therapy therapy aav9
Sio Gene Therapies Announces Corporate Updates and Fiscal First Quarter 2021 Financial Results
Published: 2021-08-12 (Crawled : 12:00) - biospace.com/
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: 1.54%
H: 4.04%
C: 3.03%
financial results gene therapies results therapy gene therapy
Sio Gene Therapies Announces Fiscal Year 2020 Year-End Financial Results and Expected Fiscal Year 2021 Key Milestones
Published: 2021-06-09 (Crawled : 12:00) - globenewswire.com
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: 1.14%
H: 7.98%
C: 4.51%
financial results gene therapies results gene therapy milestone therapy
Sio Gene Therapies to Present at the UBS Global Healthcare Virtual Conference
Published: 2021-05-19 (Crawled : 14:00) - biospace.com/
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: -2.22%
H: 1.82%
C: -0.45%
gene therapies conference therapy gene therapy
Sio Gene Therapies Announces Four Upcoming Oral Presentations at the 24th Annual Meeting of the American Society of Gene and Cell Therapy
Published: 2021-04-28 (Crawled : 14:15) - biospace.com/
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: 0.78%
H: 8.14%
C: 3.88%
presentation gene therapies therapy gene therapy
Sio Gene Therapies to Participate in Upcoming Conferences
Published: 2021-03-29 (Crawled : 12:00) - globenewswire.com
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: -0.79%
H: 0.5%
C: -0.4%
gene therapies conference therapy gene therapy
Sio Gene Therapies Provides Update on Cash Position and Major Upcoming GM1 Gangliosidosis Program Milestones
Published: 2021-03-15 (Crawled : 12:00) - biospace.com/
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: 0.71%
H: 3.52%
C: -2.46%
gene therapies positive therapy gene therapy milestone
Sio Gene Therapies to Participate in Upcoming Investor & Scientific Conferences
Published: 2021-03-11 (Crawled : 14:02) - biospace.com/
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: 2.62%
H: 2.41%
C: 1.46%
gene therapies therapy gene therapy
Sio Gene Therapies to Present at the 10th Annual SVB Leerink Global Healthcare Conference
Published: 2021-02-16 (Crawled : 12:03) - globenewswire.com
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: 0.3%
H: 3.92%
C: -0.6%
gene therapies svb leerink global therapy gene therapy
Gainers vs Losers
| 51% | 49% |
Top 10 Gainers
WISA 4 | $7.86 349.14% 120M
|
Electronic Technology
TPET | $0.4951 114.24% 29M
|
n/a
PRSO | $1.99 56.69% 52M
|
Manufacturing
PALI | $6.5 56.25% 22M
|
Manufacturing
JAGX | $0.1767 48.74% 430M
|
Health Technology
SXTC | $2.03 45.0% 27M
|
Health Technology
DYNT | $0.5255 41.87% 18M
|
Health Technology
SPCB | $0.3888 40.87% 27M
|
Electronic Technology
SNGX | $0.54 39.86% 7.3M
|
Health Technology
MCBC | $13.795 38.92% 820K
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.